Enrichment of VEGFC in the GC microenvironment could induce lymphangiogenesis, while increased CCL5 in tumor microenvironment could form a concentration gradient to recruit M2 type TAM, then promote TNF‐α secretion to increase lymphatic permeability. The gene discussed is CCL5; the disease is neoplasm.